Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Y Jiang, H Zhang, J Wang, Y Liu, T Luo… - Journal of hematology & …, 2022 - Springer
Cancer microenvironment is critical for tumorigenesis and cancer progression. The
extracellular matrix (ECM) interacts with tumor and stromal cells to promote cancer cells …

E3 ubiquitin ligases: styles, structures and functions

Q Yang, J Zhao, D Chen, Y Wang - Molecular biomedicine, 2021 - Springer
E3 ubiquitin ligases are a large family of enzymes that join in a three-enzyme ubiquitination
cascade together with ubiquitin activating enzyme E1 and ubiquitin conjugating enzyme E2 …

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review

X Li, Y Song - European Journal of Medicinal Chemistry, 2023 - Elsevier
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) identified in 2003
infected∼ 8000 people in 26 countries with 800 deaths, which was soon contained and …

Developments of CRBN-based PROTACs as potential therapeutic agents

C Wang, Y Zhang, Y Wu, D Xing - European Journal of Medicinal Chemistry, 2021 - Elsevier
Protease-targeted chimeras (PROTACs) are a new technology that is receiving much
attention in the treatment of diseases. The mechanism is to inhibit protein function by …

E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers

HB Park, KH Baek - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The mitogen-activated protein kinase (MAPK) signaling pathway is the primary regulatory
module of various cellular processes such as cell proliferation, differentiation, and stress …

DYRK1A inhibitors for disease therapy: current status and perspectives

T Liu, Y Wang, J Wang, C Ren, H Chen… - European journal of …, 2022 - Elsevier
Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a conserved
protein kinase that plays essential roles in various biological processes. It is located in the …

Protein degradation technology: a strategic paradigm shift in drug discovery

H Li, J Dong, M Cai, Z Xu, XD Cheng, JJ Qin - Journal of Hematology & …, 2021 - Springer
Targeting pathogenic proteins with small-molecule inhibitors (SMIs) has become a widely
used strategy for treating malignant tumors. However, most intracellular proteins have been …

Targeting the ubiquitin-proteasome system for cancer therapeutics by small-molecule inhibitors

G LaPlante, W Zhang - Cancers, 2021 - mdpi.com
Simple Summary The ubiquitin-proteasome system regulates multiple facets of protein
homeostasis to modulate signal transduction in numerous biological processes. Not …

Brd4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy

Y He, Y Ju, Y Hu, B Wang, S Che, Y Jian… - Journal of Controlled …, 2023 - Elsevier
Abstract Bromodomain-Containing Protein 4 (BRD4) is a member of the BET family of
bromodomains, which participates in gene transcription process and is closely related to …

Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies

TTL Nguyen, JW Kim, HI Choi, HJ Maeng, TS Koo - Molecules, 2022 - mdpi.com
ARV-110, a novel proteolysis-targeting chimera (PROTAC), has been reported to show
satisfactory safety and tolerability for prostate cancer therapy in phase I clinical trials …